1 HIV/AIDS/STI and TB (HAST), Human Sciences Research Council, Pretoria, South Africa
2 Department of Psychology, University of Limpopo, Turfloop, South Africa
3
ASEAN Institute for Health
Development, Mahidol University, Salaya, Thailand
Corresponding author:
K Peltzer (kpeltzer@hsrc.ac.za)
Objective. To identify factors associated with HIV in tuberculosis (TB) patients in a public primary healthcare (PHC) setting in South Africa (SA).
Method. Among 4 900 consecutively selected TB patients (54.5% men; women 45.5%) from 42 public PHC clinics in 3 districts in SA, a cross-sectional survey was performed to assess new TB and new TB retreatment patients within one month of anti-TB treatment.
Results. The sample comprised 76.6% new TB patients and 23.4% TB retreatment patients. Of those who had tested for HIV, 59.9% were HIV-positive; 9.6% had never tested for HIV. In multivariate analysis, older age (odds ratio (OR) 5.86; confidence interval (CI) 4.07 - 8.44), female gender (OR 0.47; CI 0.37 - 0.59), residing in an informal settlement (OR 1.55; CI 1.13 - 2.12), being a TB retreatment patient (OR 0.55; CI 0.42 - 0.72), occasions of sexual intercourse with condom use (OR 1.07; CI 1.02 - 1.13) and having a sexual partner receiving antiretroviral treatment (ART) (OR 7.09, CI 4.35 - 11.57) were associated with an HIV-positive status in TB patients.
Conclusion.
This study revealed high HIV risk behaviour (e.g. unprotected
last sexual intercourse and alcohol and drug use in the
context of sexual intercourse) among TB patients in SA.
Various factors were associated with HIV risk behaviour.
Condom use and substance use risk reduction need to be
considered as HIV-prevention measures when planning such
strategies for TB patients.
S Afr J HIV
Med 2013;14(3):125-130.
DOI:10.7196/SAJHIVMED.850
South Africa (SA) has 0.7% of the world’s population and 28% of the world’s population of HIV/tuberculosis (TB) co-infected individuals. 1 It has been estimated that approximately 60% of people with TB are co-infected with HIV. 1 Co-infected patients have almost double the chance of acquiring multidrug- (MDR-TB) and extensively drug-resistant TB (XDR-TB), and have a high mortality rate.2
Several studies have found a high level of HIV risk behaviour (e.g. multiple sexual partners, lack of condom use, intravenous drug use) among TB/HIV co-infected patients receiving anti-TB treatment.3-6 Factors associated with HIV status in TB patients have included female gender, age 26 - 35 years, unmarried marital status, a higher income, belonging to a specific population group and engaging in high-risk practices.3 , 4 , 7
The aim of this study was to
identify factors associated with HIV in TB patients in public
primary healthcare (PHC) in SA.
A cross-sectional survey was conducted
among TB patients in public PHC clinics in SA, in the three
provinces with the highest TB caseload. One district with the
highest TB caseload per province (N=3)
was ultimately included in the study: Siyanda in the Northern
Cape, Nelson Mandela Metropole in the Eastern Cape, and
eThekwini in KwaZulu-Natal. Within each district, 14 PHC
facilities (PHC clinics or community health centres) were
selected (N=42) on
the basis of the highest TB caseload per clinic. Healthcare
providers identified all new TB treatment and retreatment
patients aged ≥18 years, informed them about the study and
referred them for participation, if interested. Recruited
patients were consecutively interviewed within one month of
anti-TB treatment. Interviews were conducted by trained
external research assistants over a period of 6 months in 2011
in all 42 clinics. The research assistants asked for
permission/consent from the recruited patients to participate
in the interview. Ethical approval was granted by the Research
Ethics Committee of the Human Sciences Research Council
(protocol REC 1/16/02/11) and by the National Department of
Health.
A researcher-designed questionnaire was used
to record information on participant age, gender, educational
level, marital status, income, employment status, dwelling
characteristics and residential status. Poverty was assessed
with 5 items on the availability or non-availability of shelter,
fuel or electricity, clean water, food and cash income in the
past week. Response options ranged from 1 = ‘not one day’ to 4 =
‘every day of the week’. Poverty was defined as having a higher
score on non-availability of essential items. The total score
ranged from 5 to 20; 5 = low, 6 - 12 = medium and 13 - 20 = high
poverty. Cronbach’s α for the poverty index was 0.89 in this
sample.
The Kessler psychological distress scale
(K-10) was used to measure global psychological distress,
including significant pathology that did not meet the formal
criteria for a psychiatric illness.8
,
9 The following symptoms
were assessed by asking: ‘In the past 30 days, how often did you
feel: nervous; so nervous that nothing could calm you down;
hopeless; restless or fidgety; so restless that you could not
sit still; depressed; that everything was an effort; so sad that
nothing could cheer you up; worthless; tired out for no good
reason?’ The frequency with which each of item was experienced
was recorded using a five-point Likert scale ranging from 0 =
‘none of the time’ to 5 = ‘all the time’. This score was summed,
with increasing scores reflecting an increasing degree of
psychological distress. This scale serves to identify
individuals who are likely to meet formal definitions of anxiety
and/or depressive disorders, as well as to identify individuals
with sub-clinical illness who may not meet formal definitions
for a specific disorder.8 The scale has been validated
in HIV-positive individuals in SA.10 There was significant
agreement between the K-10 and the MINI-defined depressive and
anxiety disorders. A receiver operating characteristic (ROC)
curve analysis indicated that the K-10 showed agreeable
sensitivity and specificity in detecting depression (area under
the ROC curve (AUC) 0.77), generalised anxiety disorder (AUC
0.78) and post-traumatic stress disorder (AUC 0.77).10 The K-10
scale was used as a binary variable comparing scores ≥30 or
<30. The internal reliability coefficient for the K-10 was
α=0.92.
The 10-item alcohol use disorders
identification test (AUDIT)11 assesses alcohol
consumption level (3 items), symptoms of alcohol dependence (3
items) and problems associated with alcohol use (4 items). Heavy
episodic drinking is defined as the consumption of ≥6 standard
drinks (10 g alcohol) on a single occasion.11 A
standard drink in SA is equivalent to 12 g of alcohol. Because
the AUDIT is reported to be less sensitive at identifying risk
drinking in women, as recommended by Freeborn et al.,12 the cut-off point for binge
drinking in women (4 units) was reduced by one unit compared
with that for men (5 units). Responses to items on the AUDIT are
rated on a 4-point Likert scale from 0 to 4 (maximum score 40
points). A higher AUDIT score indicates a more severe level of
risk: a score ≥8 indicates a tendency to problematic drinking.
The AUDIT has been validated in HIV-positive patients in SA,
showing excellent sensitivity and specificity in detecting
MINI-defined dependence/abuse (AUC 0.96),13 and
among TB and HIV patients in PHC in Zambia, demonstrating good
discriminatory ability in detecting MINI-defined current alcohol
use disorders (AUDIT 0.98 for women and 0.75 for men).14
Cronbach’s α for the AUDIT in this sample was 0.92, indicating
excellent reliability.
Two questions were asked about the use of
tobacco products: (i) ‘Do you
currently use one or more of the following tobacco products
(cigarettes, snuff, chewing tobacco, cigars, etc.)?’ (response
options were ‘yes’ and ‘no’); and (ii)
‘In the past month, how often have you used one or more of the
following tobacco products (cigarettes, snuff, chewing tobacco,
cigars, etc.)?’ (response options were: ‘once or twice’,
‘weekly’, ‘almost daily’ and ‘daily’). Current tobacco use was
defined as having used any tobacco product in the past month.
Participants were asked: ‘In general, would you say your health is: excellent, very good, good, fair or poor?’ This measure was categorised based on participant response (very good = excellent/very good; good; and poor = fair/poor).
TB treatment, HIV and antiretroviral therapy (ART) status were
assessed by self-report and from medical information. HIV risk
behaviour was assessed in terms of the following: whether or not
the participant was sexually active in the past 3 months;
whether or not the last occasion of sexual intercourse was
unprotected; the number of occasions of sexual intercourse with
condom use in the past 3 months; the number of occasions of
sexual intercourse without condom use in the past 3 months;
alcohol use before sexual intercourse in the past 3 months;
illegal drug use before sexual intercourse in the past 3 months;
whether or not the participant had disclosed his/her HIV status
to the sexual partner; the HIV status of the sexual partner; and
the ART status of the sexual partner.
Data were analysed using SPSS software (version 19.0). Frequencies, means and standard deviations (SDs) were calculated to describe the sample. Data were checked for normality distribution and outliers. For non-normal distribution, non-parametric tests were used. Associations of HIV status were identified using logistic regression analyses. Following each univariate regression, multivariate regression models were constructed. Independent variables from the univariate analyses were entered into the multivariate model if significant at p<0.05. For each model, the R2 values were calculated to describe the amount of variance explained by the multivariate model. A p-value <0.05 was regarded as statistically significant.
From the sample (N=4
935) approached for inclusion in the study, 35 (0.7%) patients
declined the request to participate. The final sample included 4
900 patients (54.5% men; 45.5% women) of mean age 36.2 years (SD
±11.5; range 18 - 93). Almost two-thirds (65.2%) were aged 25 -
44 years, most (72.7%) were never married, 27.7% had completed
secondary education, 17% scored high on the poverty index, 24.2%
had a formal salary as a main household income, and 58.9% were
unemployed. A significant number of participants (15.3%) lived
in informal settlements (Table 1).
Of the total sample, 76.6% were new TB
patients and 23.4% were TB retreatment patients. Of those who
had tested for HIV, 59.9% were HIV-positive; 9.6% had never
tested for HIV. More than 1/4 patients (27.6%) were current
(past month) tobacco users, 26.3% had severe psychological
distress, and 46.3% perceived their health status as fair or
poor. Regarding sexual risk behaviour, 54.9% had had unprotected
sexual intercourse on the last occasion thereof, and 20.9% had
used alcohol and 9.3% illegal drugs before sexual intercourse in
the past 3 months. Two-thirds (63.9%) of the participants had
disclosed their HIV status, 27.2% had a sexual partner who was
HIV-positive and 11.1% had a sexual partner who
was receiving ART (Table 2).
In univariate analysis, the following were
associated with an HIV-positive status among TB patients: older
age; female gender; not being poor; black race; residing in an
informal settlement; being a TB retreatment patient; poor
perceived health status; not currently using tobacco products;
not being sexually active in the past 3 months; having
unprotected sexual intercourse on the last occasion thereof; the
number of occasions of sexual intercourse with condom use;
hazardous or harmful alcohol use; alcohol use before sexual
intercourse in the past 3 months; drug use before sexual
intercourse in the past 3 months; and having a sexual partner
who was receiving ART. In multivariate analysis, the following
were associated with an HIV-positive status in TB patients
(Table 3): older age; female gender; residing in an informal
settlement; a TB retreatment status; number of occasions of
sexual intercourse with condom use; and having a sexual partner
who was receiving ART.
This study revealed a high prevalence (59.9%) of co-infection with HIV among a large sample of TB patients in public PHC in SA, similar to the findings of other studies (60%).1 Further, there was a high level of HIV risk behaviour (last occasion of sexual intercourse unprotected, and alcohol and drug use in the context of sexual intercourse), in agreement with other studies.3-6] This is alarming, given the high rate of HIV/TB co-infection at a national level in SA.1 The dual epidemics of HIV and TB have become a public health priority, and this is beginning to receive increasing attention from the National Department of Health as specified in the National Strategic Plan 2012 - 2016.15 TB cannot, therefore, be managed as a single disease entity. A comprehensive treatment and prevention programme for TB, HIV and indeed other co-morbid disorders is required to meet this public health challenge. In the context of this study, condom use and substance use risk reduction need to be considered as HIV-prevention measures when planning HIV-prevention programmes for TB patients.
In multivariate analysis,
older age, female gender, residing in an informal settlement,
being a TB retreatment patient, occasions of sexual
intercourse with condom use, and having a sexual partner
receiving ART were associated with HIV-positive status in TB
patients. In agreement with other studies,3 sociodemographic variables
(female gender and older age) were associated with HIV status
in TB patients. In contrast, unlike in other studies,3
,
4
,
7 marital status, income,
population group and engaging in high-risk practices were not
associated with an HIV-positive status. Furthermore, TB
retreatment patients were more likely to be HIV-positive than
new TB treatment patients. These data provide information to
inform HIV-prevention strategies.
Caution should be taken when interpreting the results of this study because of certain limitations. As this was a cross-sectional study, causality between the compared variables cannot be concluded. A further limitation was that most variables were assessed by self-report and desirable responses may have been given. The population surveyed originated predominantly from urban areas, and may not be representative of other settings in SA.
This study revealed a high HIV risk behaviour among TB patients in SA. Various factors were identified associated with this behaviour, providing information for HIV-prevention strategies. Condom use and substance use risk reduction need to be considered as HIV-prevention measures when planning HIV-prevention programmes for TB patients.
Acknowledgement.
This study was funded
by a National Department of Health tender (‘NDOH: 21/2010-2011
Implementation and Monitoring of Screening and Brief
Intervention for Alcohol Use Disorders Among Tuberculosis
Patients’) awarded to the Human Sciences Research Council.
1. World Health Organization. Global TB Control Report 2010. Geneva, Switzerland: WHO, 2010.
2. National Department of Health. Tuberculosis Strategic Plan for South Africa, 2007 - 2011. Pretoria: DoH, 2007.
3. Talbot EA, Kenyon TA, Moeti TL, et al. HIV risk factors among patients with tuberculosis – Botswana 1999. Int J STD AIDS 2002;13(5):311-317.
4. Theuer CP, Hopewell PC, Elias D, et al. Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis 1990;162(1):8-12.
5. Degefa T. Survey of protective behaviour practiced against HIV/AIDS in adult TB patients at Almata Zonal Hospital. Ethiop Med J 2006;44(2):105-112.
6. Mankatittham W, Likanonsakul S, Thawornwan U, et al. Characteristics of HIV-infected tuberculosis patients in Thailand. Southeast Asian J Trop Med Public Health 2009;40(1):93-103.
7. Todd CS, Barbera-Lainez Y, Doocy SC, et al. Prevalence of human immunodeficiency virus infection, risk behavior, and HIV knowledge among tuberculosis patients in Afghanistan. Sex Transm Dis 2007;34(11):878-882. [http://dx.doi.org/10.1097/OLQ.0b013e318095068a]
8. Kessler R, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in nonspecific psychological distress. Psychol Med 2002;32:959e976.
9. Kessler RC, Barker PR, Colpe LJ, et al. Manderscheid RW, Walters EE, Zaslavsky AM. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003;60(2):184e189.
10. Spies G, Kader K, Kidd M, et al. Validity of the K-10 in detecting DSM-IV-defined depression and anxiety disorders among HIV-infected individuals. AIDS Care 2009;21(9):1163-1168. [http://dx.doi.org/10.1080/09540120902729965]
11. Babor TF, Higgins-Biddle JC. Brief intervention for hazardous and harmful drinking a manual for use in primary care. Geneva, Switzerland: World Health Organization Department of Mental Health and Substance Dependence, 2001.
12. Freeborn DK, Polen MR, Hollis JF, Senft RA. Screening and brief intervention for hazardous drinking in an HMO: Effects on medical care utilization. Journal of Behavioral Health Services Research 2000;27(4):446-453.
13. Myer L, Smit J, Roux LL, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: Prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDS 2008;22(2):147-158. [http://dx.doi.org/10.1089/apc.2007.0102]
14. Chishinga N, Kinyanda E, Weiss HA, Patel V, Ayles H, Seedat S. Validation of brief screening tools for depressive and alcohol use disorders among TB and HIV patients in primary care in Zambia. BMC Psychiatry 2011;11:75. [http://dx.doi.org/10.1186/1471-244X-11-75]
15. National Department of Health. National Strategic Plan for HIV and AIDS, STIs and TB, 2012 - 2016. Pretoria: DoH, 2011. http://www.doh.gov.za/docs/stratdocs/2012/NSPfull.pdf (accessed 1 July 2013).